Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1-7), in Acute Heart Failure: Insights from the PUSH-AHF trial
Listen to this summary
The authors aimed to investigate the levels of circulating dipeptidyl peptidase 3 (cDPP3) in patients with acute heart failure and their association with clinical characteristics, decongestive response, and outcomes. They found that higher cDPP3 concentrations were linked to impaired kidney function and reduced diuretic response, while natriuresis-guided therapy improved decongestion across different cDPP3 levels. The study suggests that further research is needed to clarify the clinical significance of cDPP3 in acute heart failure.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of cardiac failure
View all →Sep 8, 2026 · Journal of cardiac failure
From Innocence to Endurance: A Patient's Perspective on Lifelong Transplant Care
Sep 8, 2026 · Journal of cardiac failure
Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?
Sep 8, 2026 · Journal of cardiac failure
Heart Transplantation in 2076: From Scarcity to Cardiac Restoration
Sep 8, 2026 · Journal of cardiac failure
Extracorporeal Photopheresis in Heart Transplantation: From Salvage Therapy to Immunosuppression-Sparing Strategy
Sep 8, 2026 · Journal of cardiac failure
Beyond Tacrolimus: Toward Personalized Immunosuppression in Heart Transplantation
Sep 8, 2026 · Journal of cardiac failure
The Future of Donor Heart Preservation
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


